Authors' Reply - Comments: Serum levels of infliximab in Brazilian patients with Crohn's disease: what are the reasons for differences from previous studies?

Gomes, Luis Eduardo Miani; da Silva, Francesca Aparecida Ramos; Pascoal, Lívia Bitencourt; Ricci, Renato Lazarin; Nogueira, Guilherme; Camargo, Michel Gardere; de Lourdes Setsuko Ayrizono, Maria; Fagundes, João José; Leal, Raquel Franco.

Clinics; 74 (), 2019

Publication year: 2019

Anticuerpos Monoclonales, Brasil, Enfermedad de Crohn, Inmunosupresores, Infliximab

Fulltext

More related